Lupin launches Leflunomide Tablets

02 Sep 2020 Evaluate

Lupin has launched Leflunomide Tablets USP, 10 mg and 20 mg, having received an approval from the United States Food and Drug Administration (USFDA) earlier. The product would be manufactured at Lupin’s Pithampur (Unit I) facility in India.

Leflunomide Tablets USP, 10 mg and 20 mg, is the generic equivalent of Arava Tablets, 10 mg and 20 mg, of Sanofi-Aventis U.S. LLC., and is indicated for the treatment of adults with active rheumatoid arthritis (RA). Leflunomide Tablets USP (RLD: Arava) had an annual sales of approximately $42 million in the U.S. 

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2052.05 -19.30 (-0.93%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×